炎症,多巴胺能大脑和胆红素
Sri Jayanti1,2, Camilla Dalla Verde1, Claudio Tiribelli1
1Italian Liver Foundation, Liver Brain Unit "Rita Moretti", Area Science Park, Bldg. Q, SS 14, Km 163,5, 34149 Trieste, Italy.
International journal of molecular sciences
|July 29, 2023
概括
抗炎性血代谢物比利鲁保护多巴胺神经元免受炎症和细胞死亡,为帕金森病等神经退行性疾病提供潜在的治疗策略.
科学领域:
- 神经科学是一个神经科学.
- 神经炎症是一种神经炎症.
- 神经保护是一种神经保护.
背景情况:
- 多巴胺是一种关键的神经递质,与帕金森病 (PD) 以及各种认知和情感功能有关.
- 多巴氨基神经元 (DOPAn) 易受压力因素的影响,炎症被认为是神经元功能障碍和神经退行性疾病死亡的重要危险因素.
- 在影响DOPAn的非神经退行性疾病中炎症的作用不太清楚.
研究的目的:
- 审查现有的证据,将多巴胺基神经元,炎症 (特别是TNFα) 和胆红素的抗炎性质联系起来.
- 识别知识差距,并提出抗炎策略的假设,涉及胆红素维持多巴胺平衡.
- 探索胆红素在维护DOPAn功能方面的潜力.
主要方法:
- 文献综述综合了多巴胺,炎症和胆红素的研究.
- 对实体模型的分析,证明了胆红素对DOPAn对TNFα诱导损伤的保护作用.
- 探索胆红素的抗炎机制.
主要成果:
- 血红素是一种血红素代谢物,具有显著的抗炎活性.
- 比利鲁已经证明,在帕金森病的ex vivo模型中,它有能力防止多巴胺能神经元死亡.
- 比利鲁宾的神经保护作用部分通过其对瘤缩因子-α (TNFα) 的作用进行介导.
结论:
- 比利鲁代表了一种有前途的内源性抗炎剂,用于保护多巴胺基神经元.
- 用胆红素向炎症可能为在神经退行性和潜在的非神经退行性疾病中保持多巴胺平衡提供新的治疗途径.
- 需要进一步的研究来充分阐明胆红素的机制和多巴胺相关疾病的治疗潜力.
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.4K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.4K
Neural Regulation
39.5K
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
39.5K
Disorders of the Nervous Tissue
1.4K
Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
1.4K
The Blood-brain Barrier
47.6K
Overview
47.6K
Parkinson's Disease: Overview
598
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is...
598
Inflammation
53.9K
Overview
53.9K


